Opexa Therapeutics, Inc.·4

Nov 12, 6:37 AM ET

Opexa Therapeutics, Inc. 4

4 · Opexa Therapeutics, Inc. · Filed Nov 12, 2013

Insider Transaction Report

Form 4
Period: 2013-11-08
Warma Neil K
President & CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2013-11-08+50,00050,000 total
    Exercise: $1.88Exp: 2023-11-08Common Stock (50,000 underlying)
  • Award

    Common Stock

    2013-11-08+28,57145,886 total
Footnotes (1)
  • [F1]25% exercisable on date of grant with the balance vesting quarterly in equal amounts at the end of each of the next nine quarters (i.e., commencing on 12/31/13 and ending on 12/31/15).

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4